✦ LIBER ✦

Two-day aciclovir therapy is effective in patients with recurrent genital herpes

Book ID: 120863485
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2002
Weight: 151 KB
Volume: 1338
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200213380-00051

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Famciclovir vs. aciclovir in immunocompe

Famciclovir vs. aciclovir in immunocompetent patients with recurrent genital herpes infections: a parallel-groups, randomized, double-blind clinical trial

✍ O. Chosidow; Y. Drouault; F. Leconte-Veyriac; M. Aymard; J.P. Ortonne; F. Pouget 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB

Effect of Valacyclovir on Viral Shedding

Effect of Valacyclovir on Viral Shedding in Immunocompetent Patients With Recurrent Herpes Simplex Virus 2 Genital Herpes: A US-Based Randomized, Double-Blind, Placebo-Controlled Clinical Trial

✍ Fife, Kenneth H.; Warren, Terri J.; Ferrera, R. David; Young, Douglas G.; Justus 📂 Article 📅 2006 🏛 Mayo Clinic 🌐 English ⚖ 55 KB

7-day triple therapy with esomeprazole,

7-day triple therapy with esomeprazole, levefloxacin and amoxycillin is effective in patients with metronidazole- and clarithromycin-sensitive and -resistant H. pylori strains

✍ Ahmed Madisch; Ekkehard Bayerdoerffer; Elke Baestlein; Wulf Schneider-Brachert; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 171 KB

A 5-day quadruple Helicobacter pylori er

A 5-day quadruple Helicobacter pylori eradication regimen is more effective than a 7-day triple therapy regimen in patients with ulcer disease and H. pylori infection

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

Combined pegylated liposomal doxorubicin

Combined pegylated liposomal doxorubicin and bortezomib is highly effective in patients with recurrent or refractory multiple myeloma who received prior thalidomide/lenalidomide therapy

✍ Pieter Sonneveld; Roman Hajek; Arnon Nagler; Andrew Spencer; Joan Bladé; Tadeusz 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

## Abstract ## BACKGROUND Recently, the authors reported improved time to disease progression (TTP) with a combination of pegylated liposomal doxorubicin (PLD) and bortezomib compared with bortezomib alone in a phase 3 randomized trial in patients with recurrent/refractory multiple myeloma (MM). I

A four day triple therapy with rabeprazo

A four day triple therapy with rabeprazole, amoxycillin and clarithromycin in patients with peptic ulcer disease and Helicobacter pylori infection is safe and effective in 90%—a pilot study

✍ Stefan Lueth; Stephan Teyssen; Manfred V Singer 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 30 KB